U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Thousands Protest in Brazil Against Efforts to Reduce Jair Bolsonaro’s Prison Sentence
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Israeli Airstrike in Gaza Targets Senior Hamas Commander Amid Ceasefire Tensions
U.S. Intelligence Briefly Curtailed Information Sharing With Israel Amid Gaza War Concerns
Ukraine’s NATO Concession Unlikely to Shift Peace Talks, Experts Say
International Stabilization Force for Gaza Nears Deployment as U.S.-Led Planning Advances
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
New Epstein Photos Surface Showing Trump as Lawmakers Near Document Release Deadline 



